Latest Pfizer News | Page 2

Pfizer’s COVID-19 oral anti-viral available to more Australians on the Pharmaceutical Benefits Scheme from 1 April
TGA Product Information safety updates 27 March
Covid vaccine safety report – 23-03-2023
UW study investigates how ‘vaccine shopping’ impacts rollout during pandemic
Covid vaccine safety report – 09-03-2023
TGA Product Information safety updates 2 March
Australian Cell and Gene Catalyst takes step forward
ATAGI recommendations on use of Moderna bivalent Covid vaccine
Is there a vaccine for RSV or respiratory syncytial virus? After almost 60 years, several come at once
Covid vaccine safety report – 23-02-2023
TGA provisionally approves Moderna’s new bivalent Covid vaccine
New booster plan in time for winter
TGA grants provisional approval to Moderna’s COVID-19 bivalent (SPIKEVAX Bivalent Original/Omicron BA.4-5) booster dose vaccine
Victorian Heart Hospital opens: First dedicated heart hospital in the Southern Hemisphere and new home of Monash cardiovascular research
Final days to nominate stroke hero
Covid vaccine safety report – 09-02-23
Haven’t had COVID or a vaccine dose in the past six months? Consider getting a booster
COVID-19 vaccine available for younger children at higher risk of severe illness
ATAGI recommendations on use of Pfizer bivalent Covid vaccine 8 February
ATAGI 2023 booster advice
New research uncovers what Australians consider most important when it comes to their health
TGA Product Information safety updates 31 January
Covid vaccine safety report – 27-01-2023
TGA grants provisional approval to Pfizer’s COVID-19 bivalent (COMIRNATY Original/Omicron BA.4-5 COVID-19 vaccine) booster dose vaccine
China’s COVID cases may have hit 900 million. What’s headed our way?
Social entrepreneur is Oz Day Ambassador
Covid vaccine safety report – 12-01-23
How common are severe side effects from COVID vaccines? And how are they detected?
TGA Product Information safety updates 21 December
COVID Vaccine Rollout Saved Australia $181B: Modeling
COVID Vaccine Rollout Saves Australia $181 Billion
Know your COVID risk, and help yourself and others this summer
Covid vaccine to be available February 2023 for immunocompromised and high-risk under 5-year-olds
Covid vaccine safety report – 15-12-2022
Fourth death possibly linked to Covid vaccine
TGA Product Information safety updates
“We have to do a better job of utilizing our own ideas”
Immutep announces new collaboration for cancer treatment combination
Nearly two thirds of Australians are complacent about Covid despite emergence of new wave
New Covid vaccines for eligible Australians
ATAGI recommendations on use of Pfizer bivalent Covid vaccine
ATAGI recommendations on use of Pfizer Covid vaccine for children aged 6 months to 4 years
Previous COVID infection may not protect you from new subvariant wave. Are you due for booster
Previous COVID infection may not protect you from new subvariant wave
Should you really use your smartwatch or fitness wearable to monitor your heart?
New funding for Bridge Program
ATAGI recommendations for booster dose of paediatric Pfizer Covid vaccine in children aged 5
Budding pathologist untangling Covid vaccine response